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Abstract  
Background: Multifactorial regression models are frequently used in medicine to 
estimate survival rate of patients across risk groups. However, their results are not 
generalisable, if in the development of models assumptions required are not 
satisfied.  Missing data is a common problem in pathology. The aim of this paper 
is to address the danger of exclusion of cases with missing data, and to highlight 
the importance of imputation of missing data before development of multifactorial 
models. 
Methods: This study was performed on 310 breast cancer patients diagnosed in 
Shiraz (Southern Iran). Performing a complete-case Cox regression model, a 
prognostic index was calculated so as to categorise the patients into 3 risk groups. 
Then, applying the Multivariate Imputation via Chained Equations (MICE) method, 
missing data were imputed 10 times. Using imputed data sets, modelling was 
performed to assign patients into risk groups. Estimated actuarial Overal Survival 
(OS) rates corresponding to analysis of complete-case and imputed data sets 
were compared.  
Results: Cases with at least one missing datum experienced a significantly better 
survival curve. Estimates derived analysing complete-case data, relative to 
imputed data sets, underestimated the OS rate in all risk groups. In addition 
confidence intervals were wider indicating loss in precision due to attrition in 
sample size and power. 
Conclusion:  Results obtained highlighted the danger of exclusion of missing data. 
Imputation of missing data avoids biased estimates, increases the precision of 
estimates, and improves genralisability of results to other similar populations. 
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Introduction 
Cancer is one of the most major health problems 
worldwide. In 2002, a quarter of the 11 million new 
cases of cancer reported worldwide occurred in 
Europe. Among new cancer patients diagnosed in the 
UK, which is more than a quarter of a million per 
year, the most prevalent carcinomas (incidence rate) 
were breast (16%), lung (13%), bowel or colorectal 
(13%), and prostate (12%) [1]. Breast carcinoma, 
with one million newly diagnosed cases annually, is 
the most prevalent malignancy, comprising 18% of 
all female cancers [2]. 
In Iran, cancer is the third cause of deaths after 
cardiovascular diseases and accidents [3]. The breast 
cancer is the most lethal one among women. The 
prevalence of breast cancer was reported 25.4 and 
deaths due to breast cancer were 12.3 per 100,000 
[3]. 
Clinical trials typically involve collection of patient 
data at entry and in so far as are possible these 
data will include variables of potential relevance to 
the likely cause of the disease under study. These 
data sets have been used in development of 
prognostic models, which provides a valuable 
resource in identifying important risk factors for 
disease course and hence also for risk stratification 
of patients.  
However, if in development of prognostic models, 
one ignores model assumptions and limitations the 
models obtained might not be generalisable [4,5]. 
Presence of missing data is one issue which makes 
difficulties in model building. When missing data 
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present, researchers frequently drop out patients 
with missing data on any of variables under study 
from consideration. This ad hoc method is known as 
Complete-Case (C-C) analysis [6]. It has been 
emphasized that exclusion of missing data will 
diminish precision of estimates and can lead to 
biased estimates [7].  
Survival rates are frequently reported in the 
literature to compare treatment options, and to 
inform the patients about their likely outcome [8]. 
Exclusion of missing data results in biased estimate of 
cohort survival rates, in particular when there is 
difference in survival curve of cases with available 
data with the remainder (who had at least one 
missing datum) [9].  
As an example when cases with missing data, in 
comparison with those who had data available, 
exhibits lower survival curve, omission of missing data 
results in overestimation of survival rates [9]. 
Therefore, appropriate methods should be applied 
to impute missing data so as to avoid attrition in 
sample size.   
The aim of this paper is to compare estimation of 
survival rates under two scenarios: in complete-case 
analysis, and after imputation of missing data. 
Methods were applied analysing a breast cancer 
data set. 
Materials and Methods 
Patients and outcome 
From 1994 to 2003, the information of 310 
breast cancer patients in Shiraz, southern Iran were 
collected from Hospital-based Cancer Registry of 
Nemazee Hospital affiliated to Shiraz University of 
Medical Sciences. Median follow-up time was 2.5 
years. The main outcome of study was Overall 
Survival (OS). Survival was considered as the time 
period between diagnosis and death for patients 
who died, and from diagnosis to the last visit for 
censored patient. At the end of the study, there had 
been 56 deaths.  
At the first step a multifactorial model was 
developed (see the rest of the text). The OS rates 
were estimated from risk groups derived (explained 
later).  Variables offered to the multifactorial models 
were those showed to have univariate predictive 
ability [10] (tumour stage with 3 levels (early, locally 
advanced, and advanced), tumour grade with 3 
levels (1, 2, and 3), history of benign breast disease 
(positive versus negative), and age at diagnosis).  
Prior to analysis, the age variable was dichotomised 
at 48 to be a surrogate for approximate 
menopausal status [11]. 
Multifactorial Models 
At first a dummy variable was created which took 
a value of 0 if patient had available data on all 
variables under consideration and 1 otherwise. 
Survival curve of patients with and without missing 
data were compared plotting Kaplan-Meier curves 
ad performing Log-Rank test. Linear Cox model was 
then applied to develop the multifactorial regression 
models [12]. 
Complete-Case (C-C) Model 
In the C-C model, patients with missing data on 
any of 4 candidate variables were excluded. Cox 
regression model in conjunction with ENTER variable 
selection method was then fitted. A final risk score 
was calculated by multiplying variables into the 
estimated regression coefficient. Tertiles of the risk 
score estimated were applied as cut off to 
categorise patients into low, intermediate, and high 
risk groups. 
MICE Model 
Multivariable Imputation via Chained Equations 
(MICE) method is then applied to impute missing 
data. The MICE method is a powerful tool to tackle 
the missing values. The MICE method replaces each 
missing value by multiple imputed values, typically 
10, resulting in multiply imputed data sets [13,14].  
Patients' outcome and set of 4 risk factors were 
used in the MICE algorithm [15]. Polytomous and 
logistic regression were used to impute missing data 
for categorical and binary data respectively.   
The creation of 10 data sets means there is a 
requirement for 10 modelling analyses, one for each 
data set, and there will therefore be 10 different 
estimates for each parameter. A Cox regression 
model was fitted to each of 10 imputed data sets. In 
each of 10 data sets, multiplying data set specific 
estimates into the variables, a risk score was 
calculated (10 in total). Finally, for each patient a 
single averaged risk score was calculated by 
averaging her estimated risk scores from each of the 
10 imputed data sets. Tertiles of the final risk score 
was applied as cut offs to divide patients into low, 
intermediate, and high risk groups. 
Estimation of Overall Survival (OS) rates 
To compare the OS rates in risk groups, actuarial 
2, 4, and 5-year OS rates in the lowest, 
intermediate, and highest risk groups are reported. 
This was done analysing complete-case and imputed 
data sets. 
Based on definition the survival function, say S (4), is 
the probability of being alive at least till 4th year of 
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follow up. Therefore, survival at the 4th year 
depends on survival at first, second…and 4th year 
which implies that (4) ( 4)S P T= ≥ . In actuarial life-
table procedure, the whole follow-up duration will 
be split to intervals (as an example to 1 year 
intervals (0, 1], (1, 2], (2, 3], (3, 4] respectively).  If 
in  and id  show number of patients at risk just 
before the i-th interval and the number of events at 
i-th interval, then the probability of surviving to 4th 
year is given by 
4
1
( 4 ) (1 )i
i i
dS
n
=
= −∏  
Based on Greenwood’s formula the variance of 
this estimator can be estimated by  
4
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To address loss in precision of estimates, 
confidence intervals of OS rates, corresponding to 
analysis of C-C and imputed data sets, were 
estimated and compared. 
Software 
A series of packages which work under R software 
(version 2.5.1) were used [16]. Missing data were 
Table 1. Comparison of survival of patients with available data and with at least one missing datum
Group # of patients # of events Log-RankP-value 
Cases with available data on all 4 variables 203 54 <0.0001
Cases with at least 1 missing datum 107 2
 
 
Table 2. Comparison of estimated OS rates in the risk groups derived analysing complete case and 
imputed data sets 
Model Risk group 2-year OS (%)
 (95% C.I.) 
4-year OS (%)
(95% C.I.) 
5-year OS (%)
(95% C.I.) 
Complete 
Case 
Low  92 (84, 100) 84 (70, 96) 84 (70, 96)
Intermediate 79 (67, 91) 67 (51, 83) 67 (51, 83)
High 52 (38, 66) 28 (12, 44) 16 (0, 32)
Imputed 
data set 
Low  95 (91, 99) 90 (82, 98) 90 (82, 98)
Intermediate 88 (80, 96) 82 (70, 94) 82 (70, 94)
High 64 (52, 76) 42 (28, 56) 32 (16, 48)
6.004.002.000.00
Pro
po
rtio
n a
live
1.0
0.8
0.6
0.4
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Figure 1. K-M curves for cases with available data and cases with at least one. 
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imputed using MICE package [17]. Performance of 
models (discrimination and predictive ability) were 
assessed using Design [18] library. K-M curves are 
plotted using SPSS software. 
Results 
The numbers (percentages) of patients with missing 
value on node status, grade, and history of benign 
disease were 63 (20.3%), 64 (20.6%), and 47 
(15.2%) respectively. In total, out of 310 patients, 
203 cases (65%) had data available on all 4 
variables of which 54 had died.  
Table 1 reports the number of deaths for patients 
with complete data and the remainder with at least 
one missing datum. Corresponding K-M curves is 
plotted in Figure 1. Cases with complete data had 
much lower survival curve (Log-Rank P-value 
<0.0001). This indicates that exclusion of cases with 
missing data leads to underestimation of the true OS 
rates in the cohort analysed.  
As explained in methods section a risk score was 
estimated for complete-case and imputed data sets. 
Using tertiles as cut off, patients were categorised 
into 3 risk groups (low, intermediate, and high). 
Estimated OS rates in risk groups derived are 
summarised in Table 2.  Estimations derived 
analysing patients with available data, 
underestimated OS rates in all 3 risk groups. This 
was the case in all 3 risk groups, and time points. For 
example, estimated 2-year OS rate in lowest risk 
group for complete-case ad imputed data sets were 
92% and 95% respectively. Corresponding rates at 
4 years were 84% and 90% respectively. 
Furthermore, C.I.'s corresponding to imputed data 
sets, relative to complete-case data, was tighter since 
attrition in sample size is avoided. 
Discussion 
We have seen that confidence intervals of OS 
rates corresponding to the imputed data sets were 
narrower indicating improvement in precision of 
estimates. Furthermore, comparing K-M curves of 
patients with available data with those with at least 
one missing datum suggested that exclusion of 
missing data leads to underestimation of OS rates. 
This was consistent with estimated we obtained which 
are summarised in Table 2. 
To provide more accurate estimates, we imputed 
missing data 10 times. This was to protect against 
chance effects dues to imputation. This protection was 
to be felt worth the inconvenience of having to 
average risk scores across 10 final models. Easier 
imputation methods such as Expectation Maximum (E-
M) algorithm are likelihood based and suitable 
approaches. However, E-M method replaces each 
missing data by a single value so does not take into 
account imputation uncertainty.  
It has been noted that under the Missing 
Completely At Random (MCAR) assumption, subjects 
with complete data are a random sample of data 
[19]. It has been argued that under MCAR 
mechanism if missing rate is less than 5%, case 
deletion is a reasonable approach [20]. However, it 
should be emphasized that even when C-C analysis 
give results comparable to the MICE, a gold 
standard (MICE) is required to compare results from 
other simpler methods [21]. 
On the other hand, when missing rate is high, 
exclusion of missing data will diminish precision of 
estimates. Another issue is that even a low rate of 
missing data on each variable might cause serious 
problems in multivariate modelling when patients 
with missing data on are scattered across the data. 
That is because this might substantially reduce the 
number of complete cases available for analysis, 
and increase the chance of bias due to excluded 
cases.  
There are lots of ad hoc (such as C-C, replacement 
by mean, and missing indicator approaches) and 
maximum likelihood methods (such as E-M algorithm, 
and multiple imputation technique) to deal with 
missing data [22]. Application and comparison of 
alternative imputation methods was beyond the 
scope of this paper and will be published elsewhere.  
The ultimate consequence of complete-case 
analysis is power reduction. In addition, case-deletion 
might result in biased regression coefficients if the 
remaining cases are not the representative of the 
whole sample [7,23]. Results presented showed that 
exclusion of cases with missing data leads to bias 
and imprecise estimates. Therefore imputation of 
missing data should be a prime before any 
modelling practice. 
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